Vilarinho Sílvia, Erson-Omay E Zeynep, Mitchell-Richards Kisha, Cha Charles, Nelson-Williams Carol, Harmancı Akdes Serin, Yasuno Katsuhito, Günel Murat, Taddei Tamar H
Department of Internal Medicine, Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT, USA; Department of Genetics, Yale School of Medicine, New Haven, CT 06510, USA.
Department of Neurosurgery, Yale Program in Brain Tumor Research, Yale School of Medicine, New Haven, CT, USA.
J Hepatol. 2017 Jul;67(1):186-191. doi: 10.1016/j.jhep.2017.03.009. Epub 2017 Mar 18.
Hepatocellular adenoma (HCA) is a rare benign liver tumor, predominantly seen in young women. Its major complications are malignant transformation, spontaneous hemorrhage, and rupture. We describe a case of a young female with no underlying liver disease who presented with acute abdominal pain and was found to have a 17cm heterogeneous mass in the left lobe of the liver. She underwent left hepatectomy and pathology revealed a 14cm moderately differentiated hepatocellular carcinoma (HCC) arising in a shell of a HCA. At that time, vascular invasion was already present. She rapidly developed recurrent multifocal hepatic lesions and subsequent spread to the brain, leading to her death 18months after surgery. To investigate the underlying genetic events occurring during hepatocellular adenoma-carcinoma transition and extra-hepatic dissemination, we performed whole exome sequencing of DNA isolated from peripheral blood leucocytes, HCA, HCC, tumor thrombus and brain metastasis. Our data show a step-wise addition of somatic mutations and copy number variations with disease progression, suggesting a linear tumor evolution, which is supported by clonality analysis. Specifically, using a model based clustering of somatic mutations, one single founding clone arising in the HCA, which included catenin beta 1 (CTNNB1) and IL6ST driver mutations, was identified and displayed an increasing clonality rate in HCC, tumor thrombus and brain metastasis. Our data highlight the feasibility of performing whole exome capture, sequencing and analysis using formalin-fixed paraffin-embedded (FFPE) samples, and we describe the first genomic longitudinal study of hepatocellular adenoma-carcinoma transition, vascular invasion and brain metastasis with detailed clinicopathologic annotation.
肝细胞腺瘤(HCA)是一种罕见的肝脏良性肿瘤,主要见于年轻女性。其主要并发症为恶变、自发性出血和破裂。我们描述了一例无基础肝脏疾病的年轻女性病例,该患者因急性腹痛就诊,发现肝脏左叶有一个17cm的异质性肿块。她接受了左半肝切除术,病理显示在肝细胞腺瘤的包膜内出现了一个14cm的中度分化肝细胞癌(HCC)。当时已经存在血管侵犯。她迅速出现复发性多灶性肝内病变,随后扩散至脑部,术后18个月死亡。为了研究肝细胞腺瘤-癌转变及肝外播散过程中发生的潜在基因事件,我们对从外周血白细胞、肝细胞腺瘤、肝细胞癌、肿瘤血栓和脑转移灶中分离的DNA进行了全外显子组测序。我们的数据显示,随着疾病进展,体细胞突变和拷贝数变异逐步增加,提示肿瘤呈线性演变,这一结论得到了克隆性分析的支持。具体而言,通过基于体细胞突变的模型聚类分析,我们鉴定出一个起源于肝细胞腺瘤的单一始祖克隆,其中包括连环蛋白β1(CTNNB1)和IL6ST驱动基因突变,并且该克隆在肝细胞癌、肿瘤血栓和脑转移灶中的克隆率逐渐增加。我们的数据突出了使用福尔马林固定石蜡包埋(FFPE)样本进行全外显子组捕获、测序和分析的可行性,并且我们描述了首例肝细胞腺瘤-癌转变、血管侵犯和脑转移的基因组纵向研究,并伴有详细的临床病理注释。